Consumers who take GLP-1 drugs might switch what they eat, but they largely spend the same amount of money on CPG food and ...

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

New Anglo/U.S. obesity and cardiometabolic specialist Verdiva Bio Ltd. has launched with a massive $411 million series A and ...

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

Medspas are leading the charge in offering GLP-1 treatments, with 60% of medspas in the U.S. now providing these services, compared to 35% of aesthetic physician offices. Average spend per patient ...

Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

That can create a “potential snowball effect” of bias that further amplifies human behavior, one researcher said in a press release, partly because the authors said people seem to believe AI is more ...

Analysts forecast a slightly rosier year, predicting that consumer demand will rise, bankruptcies will slow and increased ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...